School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Jyong Biotech Ltd. MENS

Healthcare · Biotechnology

$2.10last close 2026-10-09 · market cap $159.66M · delayed data

Trailing returns

1M-2.78%
3M-8.70%
6M-21.64%
1Y-96.12%

Basis: Adjusted daily closes.

What it does

Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.

Open MENS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies